BENITIONSClinical Trial Intelligence

FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease

該当なし 完了 NCT05504811

対象疾患Cognitive Dysfunction, Dementia, Mild
該当なし
スポンサーFlint Rehabilitation Devices, LLC
ステータス完了
参加者数31 名
介入(薬剤)FitMi AD, Conventional exercise program
開始日2023年9月8日
完了日2025年3月12日
結果公開日2026年7月20日

概要

This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.

Change in Functional Reach Test

Baseline, Immediately Post-Treatment (an average of 3 months) · centimeters

Experimental: FitMi AD Exercise Program-0.21 ± 2.27 centimeters
Active Comparator: Conventional Booklet of Exercise Program-0.16 ± 3.36 centimeters
p-value0.96

Change in Timed Up and Go Test

Baseline, Immediately Post-Treatment (an average of 3 months) · Seconds

Experimental: FitMi AD Exercise Program-0.50 ± 3.33 Seconds
Active Comparator: Conventional Booklet of Exercise Program-1.05 ± 2.77 Seconds
p-value0.63

Change in 30 Second Chair Stand Test

Baseline, Immediately Post-Treatment (an average of 3 months) · number of times the patient stands in 30

Experimental: FitMi AD Exercise Program-0.07 ± 0.59 number of times the patient stands in 30
Active Comparator: Conventional Booklet of Exercise Program-0.19 ± 0.53 number of times the patient stands in 30
p-value0.59

BENITIONS で見る ClinicalTrials.gov の原文を見る

同じ疾患の他の治験

すべての治験

このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。